The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings

dc.contributor.authorAbrahams, Zulfa
dc.contributor.authorDave, Joel A
dc.contributor.authorMaartens, Gary
dc.contributor.authorLesosky, Maia
dc.contributor.authorLevitt, Naomi S
dc.date.accessioned2015-01-17T09:34:59Z
dc.date.available2015-01-17T09:34:59Z
dc.date.issued2014-08-04
dc.date.updated2015-01-15T17:52:25Z
dc.description.abstractAbstract Background Lipohypertrophy does not appear to be an adverse ART reaction while lipoatrophy is clearly associated with the use of stavudine (d4T) and zidovudine (AZT). In low and middle income countries d4T has only recently been phased out and AZT is still widely being used. Several case definitions have been developed to diagnose lipodystrophy, but none of them are generalizable to sub-Saharan Africa where black women have less visceral adipose tissue and more subcutaneous adipose tissue than white women. We aimed to develop a simple, objective measure to define lipoatrophy and lipohypertrophy by comparing patient report to anthropometric and dual-energy X-ray absorptiometry (DXA) -derived variables. Methods DXA and anthropometric measures were obtained in a cross sectional sample of black HIV-infected South African men (n = 116) and women (n = 434) on ART. Self-reported information on fat gain or fat loss was collected using a standard questionnaire. Receiver operating characteristic (ROC) curves were used to describe the performance of anthropometric and DXA-derived variables using patient reported lipoatrophy and lipohypertrophy as the reference standard. Results Lipoatrophy and lipohypertrophy were more common in women (25% and 33% respectively) than in men (10% and 13% respectively). There were insufficient numbers of men with DXA scans for meaningful analysis. The best predictors of lipoatrophy in women were the anthropometric variables tricep (AUC = 0.725) and thigh skinfold (AUC =0.720) thicknesses; and the DXA-derived variables percentage lower limb fat (AUC = 0.705) and percentage lower limb fat/height (AUC = 0.713). The best predictors of lipohypertrophy in women were the anthropometric variable waist/hip ratio (AUC = 0.645) and the DXA-derived variable percentage trunk fat/percentage limb fat (AUC = 0.647). Conclusions We were able to develop simple, anthropometric measures for defining lipoatrophy and lipohypertrophy, using a sample of black HIV-infected South African women with DXA scans. This is of particular relevance in resource limited settings, where health professionals need simple and inexpensive methods of diagnosing patients with lipoatrophy and lipohypertrophy.en_ZA
dc.identifier.apacitationAbrahams, Z., Dave, J. A., Maartens, G., Lesosky, M., & Levitt, N. S. (2014). The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings. <i>AIDS Research and Therapy</i>, http://hdl.handle.net/11427/12259en_ZA
dc.identifier.chicagocitationAbrahams, Zulfa, Joel A Dave, Gary Maartens, Maia Lesosky, and Naomi S Levitt "The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings." <i>AIDS Research and Therapy</i> (2014) http://hdl.handle.net/11427/12259en_ZA
dc.identifier.citationAIDS Research and Therapy. 2014 Aug 04;11(1):26en_ZA
dc.identifier.ris TY - Journal Article AU - Abrahams, Zulfa AU - Dave, Joel A AU - Maartens, Gary AU - Lesosky, Maia AU - Levitt, Naomi S AB - Abstract Background Lipohypertrophy does not appear to be an adverse ART reaction while lipoatrophy is clearly associated with the use of stavudine (d4T) and zidovudine (AZT). In low and middle income countries d4T has only recently been phased out and AZT is still widely being used. Several case definitions have been developed to diagnose lipodystrophy, but none of them are generalizable to sub-Saharan Africa where black women have less visceral adipose tissue and more subcutaneous adipose tissue than white women. We aimed to develop a simple, objective measure to define lipoatrophy and lipohypertrophy by comparing patient report to anthropometric and dual-energy X-ray absorptiometry (DXA) -derived variables. Methods DXA and anthropometric measures were obtained in a cross sectional sample of black HIV-infected South African men (n = 116) and women (n = 434) on ART. Self-reported information on fat gain or fat loss was collected using a standard questionnaire. Receiver operating characteristic (ROC) curves were used to describe the performance of anthropometric and DXA-derived variables using patient reported lipoatrophy and lipohypertrophy as the reference standard. Results Lipoatrophy and lipohypertrophy were more common in women (25% and 33% respectively) than in men (10% and 13% respectively). There were insufficient numbers of men with DXA scans for meaningful analysis. The best predictors of lipoatrophy in women were the anthropometric variables tricep (AUC = 0.725) and thigh skinfold (AUC =0.720) thicknesses; and the DXA-derived variables percentage lower limb fat (AUC = 0.705) and percentage lower limb fat/height (AUC = 0.713). The best predictors of lipohypertrophy in women were the anthropometric variable waist/hip ratio (AUC = 0.645) and the DXA-derived variable percentage trunk fat/percentage limb fat (AUC = 0.647). Conclusions We were able to develop simple, anthropometric measures for defining lipoatrophy and lipohypertrophy, using a sample of black HIV-infected South African women with DXA scans. This is of particular relevance in resource limited settings, where health professionals need simple and inexpensive methods of diagnosing patients with lipoatrophy and lipohypertrophy. DA - 2014-08-04 DB - OpenUCT DO - 10.1186/1742-6405-11-26 DP - University of Cape Town J1 - AIDS Research and Therapy LK - https://open.uct.ac.za PB - University of Cape Town PY - 2014 T1 - The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings TI - The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings UR - http://hdl.handle.net/11427/12259 ER - en_ZA
dc.identifier.urihttp://dx.doi.org/10.1186/1742-6405-11-26
dc.identifier.urihttp://hdl.handle.net/11427/12259
dc.identifier.vancouvercitationAbrahams Z, Dave JA, Maartens G, Lesosky M, Levitt NS. The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings. AIDS Research and Therapy. 2014; http://hdl.handle.net/11427/12259.en_ZA
dc.languageengen_ZA
dc.language.rfc3066en
dc.publisherBioMed Centralen_ZA
dc.publisher.departmentDivision of Endocrinology and Diabetologyen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rightsCreative Commons Attribution 4.0 International (CC BY 4.0)*
dc.rights.holderAbrahams et al.; licensee BioMed Central Ltd.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_ZA
dc.sourceAIDS Research and Therapyen_ZA
dc.source.urihttp://www.aidsrestherapy.com/
dc.subject.otherLipoatrophy
dc.subject.otherLipohypertrophy
dc.subject.otherLipodystrophy
dc.subject.otherAntiretroviral therapy
dc.titleThe development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settingsen_ZA
dc.typeJournal Articleen_ZA
uct.type.filetype
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12981_2014_Article_316.pdf
Size:
487.64 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections